What did @filmedwithvictoria actually say?
She said she started "micro-dosing" something she calls "Reddit" about a week ago, describing it as a "triple threat" compared to GLP-1 medications. In that first week, she reported complete elimination of food noise, an elevated heart rate, cold sensitivity, skin sensitivity, and jeans that already felt looser. She started at "one milligram" and found it "too strong," scaling back to ".5" and shifting to twice-weekly dosing.
The term "Reddit" here almost certainly refers to Retatrutide, an experimental triple agonist peptide targeting GLP-1, GIP, and glucagon receptors simultaneously. That context matters enormously for evaluating what she experienced and what she got right or wrong about it.
Does the science back this up?
Some of what she described is consistent with the known pharmacology of retatrutide, but the framing around it is loose enough to be genuinely misleading. The cardiovascular and thermoregulatory effects she felt are real documented phenomena, not placebo.
Retatrutide was studied in a Phase 2 trial (Jastreboff et al., 2023, New England Journal of Medicine) involving 338 adults with obesity. Over 48 weeks, participants on the highest dose lost an average of 17.5% of body weight, which is a meaningful result. The trial also documented nausea, vomiting, and gastrointestinal side effects as the most common adverse events. Elevated heart rate is a known class effect of GLP-1 receptor agonists broadly, and glucagon receptor agonism can drive thermogenic and sympathomimetic-type responses, which tracks with her feeling cold and heart racing. However, this compound is not approved by the FDA. It is not commercially available as a regulated pharmaceutical product. What she is using is sourced outside any regulated pharmaceutical pathway, which introduces real questions about purity, accurate dosing, and safety oversight.
What did they get wrong (or right)?
She got a few things right. The side effect profile she described, elevated heart rate, temperature sensitivity, and skin sensations, is consistent with what the clinical literature shows for triple agonist compounds. Her instinct to reduce her dose after an uncomfortable first experience is reasonable harm-reduction behavior, and saying "do your research" is at least nominally correct advice.
But here is where she went wrong. Calling one week of loose jeans "mind blown" results glosses over that weight changes in week one of any caloric-suppressing agent are largely water weight and glycogen depletion, not fat loss. The Jastreboff 2023 trial used carefully titrated doses under medical supervision over nearly a year. Framing a self-titrated, unregulated peptide as a "triple threat" better than existing GLP-1 options is not a clinical comparison she is equipped to make. The compound she is using has not completed Phase 3 trials. Comparing it favorably to approved medications based on one week of personal experience is the kind of claim that sends people down genuinely risky paths.
What should you actually know?
Retatrutide is real, and the early trial data is legitimately interesting to researchers. But interesting trial data and something you should inject into yourself based on a TikTok are very different categories.
The cardiovascular effects she described, specifically the racing heart, are not trivial. GLP-1 and glucagon receptor co-agonism has been associated with increased resting heart rate in clinical settings. A sustained or significant increase in heart rate without medical monitoring is a reason to stop, not to just reduce the dose and continue. Skin sensitivity and cold sensations can indicate vasomotor or autonomic responses that warrant evaluation, not just self-adjustment. Peptides sourced from research chemical suppliers or compounding pharmacies operating outside standard pharmaceutical manufacturing are not subject to the same purity or potency verification as FDA-approved drugs. You do not actually know what is in the vial or whether the stated dose is accurate. If you are curious about peptide therapies for weight management or metabolic health, that conversation belongs with a licensed provider who can review your full health history, not with a dosing protocol built around what felt too strong last Tuesday.